Medication info

Acarb Tablets 120/40 mg (Pimasartan Potassium, Atorvastatin)

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate Granules›300mg / 1 tabletAtorvastatin Calcium Trihydrate›20.8mg / 1 tablet
Manufacturer / importer
Boryung Co., Ltd.
Appearance
Orange rectangular film-coated tablets
Packaging
30 tablets/box [6 tablets/PTP*5]
Approval status
Active

MFDS item code 202003221 · Approved 2020.04.29

Summary

Main use
Treatment of essential hypertension, improvement of dyslipidemia, prevention of cardiovascular disease (myocardial infarction, etc.)
Who takes it
Adults
Adult dose
Take 1 tablet once daily with water, regardless of meals. It is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. This drug is for adults only. The dose should be individualized for each patient based on the effects and tolerability of each component, fimasartan and atorvastatin. Patients receiving fimasartan and atorvastatin as separate products may switch to this drug (a combination product with the same amount of each active ingredient) for convenience of administration. ○ Fimasartan 1. Adults The recommended dose of this drug is 30 ~ 60 milligrams once daily, regardless of meals. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. It is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks ~ 12 weeks. 2. Elderly patients No initial dose adjustment is required in elderly patients aged 70 years or younger. 3. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). In patients with severe renal impairment (creatinine clearance < 30 mL/min), initiate treatment at 30 milligrams once daily and do not exceed 60 milligrams per day. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. Do not administer this drug to patients with moderate ~ severe hepatic impairment. 5. Patients with decreased effective circulating blood volume (e.g., patients taking high doses of diuretics) For patients at high risk of hypotension, such as those with decreased effective circulating blood volume, an initial dose of 30 milligrams once daily is recommended. ○ Atorvastatin Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The drug may be taken at any time of day, regardless of food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses of this drug should be individualized according to patient characteristics, taking into account the treatment goal and response. Analyze lipid levels within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and adjust the dose accordingly. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. Patients with renal impairment: Renal disease does not affect atorvastatin plasma concentrations or its LDL cholesterol-lowering effect; therefore, no dose adjustment is required. Elderly patients: The efficacy and safety in patients aged 70 years and older are similar to those in the general adult patient population.

Ingredients

Manufacturer
Boryung Co., Ltd.

Efficacy & effects

Treatment of essential hypertension, improvement of dyslipidemia, prevention of cardiovascular disease (myocardial infarction, etc.)

  • Essential hypertension
  • hypercholesterolemia
  • dyslipidemia
  • primary dysbetalipoproteinemia
  • elevated serum triglycerides
  • homozygous familial hypercholesterolemia
View approved original text

This medication is used for patients who need to take both ingredients, Pimasartan and Atorvastatin. Pimasartan helps treat essential hypertension. Atorvastatin reduces the risk of cardiovascular diseases and decreases the risk of myocardial infarction and stroke in adults with multiple risk factors for coronary heart disease or type 2 diabetes patients. It can also reduce the risk of myocardial infarction, stroke, angina, and hospitalization for heart failure in patients who already have coronary heart disease. It is also used to treat hyperlipidemia, significantly contributing to reducing total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels while increasing HDL cholesterol levels when combined with diet. Therefore, this medication is used to improve hypertension, cardiovascular disease risk, and hyperlipidemia.

How to take

Adult dose

Take 1 tablet once daily with water, regardless of meals. It is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. This drug is for adults only. The dose should be individualized for each patient based on the effects and tolerability of each component, fimasartan and atorvastatin. Patients receiving fimasartan and atorvastatin as separate products may switch to this drug (a combination product with the same amount of each active ingredient) for convenience of administration. ○ Fimasartan 1. Adults The recommended dose of this drug is 30 ~ 60 milligrams once daily, regardless of meals. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. It is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks ~ 12 weeks. 2. Elderly patients No initial dose adjustment is required in elderly patients aged 70 years or younger. 3. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). In patients with severe renal impairment (creatinine clearance < 30 mL/min), initiate treatment at 30 milligrams once daily and do not exceed 60 milligrams per day. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. Do not administer this drug to patients with moderate ~ severe hepatic impairment. 5. Patients with decreased effective circulating blood volume (e.g., patients taking high doses of diuretics) For patients at high risk of hypotension, such as those with decreased effective circulating blood volume, an initial dose of 30 milligrams once daily is recommended. ○ Atorvastatin Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The drug may be taken at any time of day, regardless of food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses of this drug should be individualized according to patient characteristics, taking into account the treatment goal and response. Analyze lipid levels within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and adjust the dose accordingly. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. Patients with renal impairment: Renal disease does not affect atorvastatin plasma concentrations or its LDL cholesterol-lowering effect; therefore, no dose adjustment is required. Elderly patients: The efficacy and safety in patients aged 70 years and older are similar to those in the general adult patient population.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy, particularly in the second and third trimesters. If pregnancy is confirmed, use should be discontinued immediately. This medication may cause muscle abnormalities, so if symptoms of muscle pain or weakness occur, consult a doctor immediately. Patients with allergies to any of the ingredients, liver disease, muscle disease, those undergoing dialysis, pregnant women, or nursing mothers should not take this medication. Patients with impaired liver or kidney function, the elderly, and those with alcoholism should use this medication with caution and may require regular testing. As this medication lowers blood pressure, symptoms of hypotension (dizziness, fainting, etc.) may occur at the beginning of treatment or with increased dosage, so caution is necessary. There may be an increased risk of side effects when combined with alcohol or certain medications, so patients should inform their doctor or pharmacist of any other medications they are taking. Patients should inform healthcare personnel immediately if symptoms such as muscle pain, fever, or fatigue occur during treatment, and blood tests may be needed to check for muscle damage. This medication is not recommended for children under 10 years of age as safety and efficacy have not been established. Women who may become pregnant should use appropriate contraceptive methods while taking this medication, and nursing mothers are advised to discontinue either breastfeeding or this medication.

Side effects

  • Headache
  • dizziness
  • increased serum creatine phosphokinase
  • abnormal liver enzyme levels
  • increased ALT
  • elevated serum lactate dehydrogenase
  • increased liver enzyme levels
  • hypokalemia
  • fatigue
  • edema
Show 284 more
  • myalgia
  • hypertension
  • ventricular extrasystole
  • syncope
  • sedation
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • decreased platelet count
  • cough
  • muscle contraction
  • muscular rigidity
  • pruritus
  • localized urticaria
  • facial flushing
  • flushing
  • erectile dysfunction
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • cerebral infarction exacerbation
  • cerebral hemorrhage
  • liver cancer
  • colorectal carcinoma
  • neoplasm of unspecified nature
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • pulmonary fibrosis
  • pharyngitis
  • pneumonia
  • pulmonary disease
  • death
  • exacerbation of low back pain
  • osteoarthritis
  • arthralgia
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic coarctation
  • heart failure
  • elevated blood pressure
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronal inflammation
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal stenosis
  • weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fever
  • rhinopharyngitis
  • hyperglycemia
  • weight gain
  • loss of appetite
  • constipation
  • abdominal bloating
  • diarrhea
  • throat and larynx pain
  • epistaxis
  • insomnia
  • nightmares
  • sensory disturbance
  • sensory loss
  • taste disturbance
  • amnesia
  • peripheral neuropathy
  • arthralgia
  • limb pain
  • muscle cramps
  • joint swelling
  • back pain
  • muscle fatigue
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorder
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • allergic reaction
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function test
  • increased serum CK
  • positive urine leukocytes
  • hyperthyroidism
  • hypothyroidism
  • increased TSH
  • elevated ACTH
  • decreased aldosterone
  • gynecomastia
  • elevated potassium
  • increased BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • panic reaction
  • Alzheimer's disease
  • suicide attempt
  • anxiety
  • depression
  • hypothyroidism
  • increased TSH
  • benign pituitary neoplasm
  • atrial fibrillation
  • bradycardia
  • arrhythmia
  • tachycardia
  • myeloproliferative disorder
  • exacerbation of anemia
  • iron deficiency anemia
  • ear ringing
  • hearing impairment
  • hearing loss
  • pelvic inflammatory disease
  • vaginitis
  • uterine prolapse
  • prostate enlargement
  • scrotal pain
  • blood pressure fluctuations
  • fatty liver
  • localized inflammation
  • soft tissue infection
  • lymphadenopathy
  • postoperative pain
  • heat intolerance
  • fall
  • neck/shoulder pain
  • fracture
  • arthralgia
  • osteoporosis
  • myalgia
  • pharyngitis
  • upper respiratory infection
  • sputum
  • rhinitis
  • epistaxis
  • bronchitis
  • sensory disturbance
  • numbness
  • tremors
  • hypertonia
  • insomnia
  • anxiety
  • memory impairment
  • loss of appetite
  • gastroesophageal reflux
  • gastritis
  • diarrhea
  • constipation
  • functional gastrointestinal disorder
  • gastroenteritis
  • frequent urination
  • urinary incontinence
  • kidney stones
  • chronic renal failure
  • dysuria
  • hyperlipidemia
  • dyslipidemia
  • hypoglycemia
  • chest pain
  • low back pain
  • limb pain
  • facial swelling
  • fever
  • neck pain
  • muscle weakness
  • tendinitis
  • osteomyelitis
  • shoulder rotator cuff syndrome
  • lateral epicondylitis
  • synovitis
  • sciatica
  • jaw pain
  • arthrosis
  • osteoporosis
  • muscle weakness
  • pulmonary tuberculosis
  • armpit pain
  • periorbital edema
  • allergy
  • chills
  • nasal polyps
  • pneumonia
  • hemoptysis
  • exacerbation of rhinitis
  • asthma
  • pulmonary granuloma
  • abnormal chest X-ray
  • bronchitis
  • exacerbation of chronic renal failure
  • cystitis
  • urinary tract infection
  • increased BUN
  • pyelonephritis
  • frequent urination
  • otitis media
  • fungal infection
  • abscess
  • bacterial infection
  • genital herpes
  • cold sores
  • shingles
  • colorectal carcinoma
  • liver cancer
  • cervical cancer
  • thrombocytosis
  • panic reaction
  • Alzheimer's disease
  • suicide attempt
  • anxiety
  • insomnia
  • depression
  • hyperthyroidism
  • hypothyroidism
  • increased TSH
  • benign pituitary neoplasm
  • atrial fibrillation
  • bradycardia
  • arrhythmia
  • tachycardia
  • myeloproliferative disorder
  • exacerbation of anemia
  • iron deficiency anemia
  • ear ringing
  • hearing impairment
  • hearing loss
  • pelvic inflammatory disease
  • vaginitis
  • uterine prolapse
  • prostate enlargement
  • scrotal pain
  • blood pressure fluctuations
  • fatty liver
  • localized inflammation
  • soft tissue infection
  • lymphadenopathy
  • postoperative pain
  • heat intolerance
  • fall

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to avoid extremely hot or cold environments and store it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Orange rectangular film-coated tablets

Package unit

30 tablets/box [6 tablets/PTP*5]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.